Home World News Quadruplet Isa-KRd Regimen Improves NGS-MRD Negativity in Transplant-Eligible Patients with Newly Diagnosed... World News Quadruplet Isa-KRd Regimen Improves NGS-MRD Negativity in Transplant-Eligible Patients with Newly Diagnosed Multiple Myeloma By Ogkologos - April 20, 2026 334 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the EMN24 IsKia study Source RELATED ARTICLESMORE FROM AUTHOR Can ctDNA guide treatment intensification in EGFR mutated non-small cell lung cancer? How to select adjuvant endocrine therapy for postmenopausal women with HR-positive early breast cancer? EMA Recommends Extension of Therapeutic Indications for Abiraterone Acetate MOST POPULAR NRG1 Fusion–positive Lung Cancers are Molecularly, Pathologically, and Clinically More Heterogeneous... June 8, 2021 EMA Recommends Extension of Indications for Avelumab December 17, 2020 AI and remote monitoring are shaping a new patient journey in... August 26, 2025 E-cigarettes: what we know and what we don’t April 26, 2021 Load more HOT NEWS Plans for NCI’s Fiscal Year 2019 Budget Longitudinal Molecular Profiling of CTCs Captures New Insights in mRCC Adjuvant Olaparib Continues to Improve Multiple Outcomes in Patients with Germline... Researchers Find a Way to Prevent Cancer Cells from Taking in...
